A clinical trial on semaglutide, the active ingredient in Ozempic, and metformin, a drug used to lower blood sugar levels in patients with Type 2 diabetes, is currently being conducted, says Dr
The extensive safety data and proven cardiovascular benefits make Semaglutide a reliable option for those prioritizing established track records
To help prevent muscle loss, experts recommend strength-training exercises, adequate protein intake, and proper hydration throughout treatment
In general, the longer-acting GLP-1 agonists which are injected weekly, such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro), are associated with greater weight loss than the shorter-acting GLP-1 agonists such as liraglutide (Saxenda)
But it can take up to four to five weeks before the drug reaches a steady concentration in your bloodstream